Skip to content

Underlying factors related to up-titration of sacubitril/valsartan in patients with heart failure

Underlying factors related to up-titration of sacubitril/valsartan in patients with heart failure - Underlying factors related to up-titration of sacubitril/valsartan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044351
Enrollment
175
Registered
2021-06-01
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

None listed

Sponsors

Kindai University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with sacubitril/valsartan initiation in our hospital

Exclusion criteria

Exclusion criteria: Patients have already received sacubitril/valsartan in other hospital Lacking of follow-up information

Design outcomes

Primary

MeasureTime frame
Comparison of clinical factors between patients with and without up-titration

Countries

Japan

Contacts

Public ContactKoichiro Matsumura

Kindai University Department of Cardiology

kmatsumura1980@yahoo.co.jp+81723660221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026